Ignite Creation Date:
2024-05-06 @ 12:11 AM
Last Modification Date:
2024-10-26 @ 10:46 AM
Study NCT ID:
NCT01519375
Status:
COMPLETED
Last Update Posted:
2012-05-30
First Post:
2012-01-23
Brief Title:
Assessment of NSAID-treated Patients Adherence to Co-prescribed Proton Pump Inhibitor PPI
Sponsor:
AstraZeneca
Organization:
AstraZeneca
Study Overview
Official Title:
Cross-sectional Observational Real Life Study on NSAIDs Treated Patients With Osteoarthritis Rheumatoid Arthritis and Ankylosing Spondylitis Assessment of Patient Adherence to PPI Treatment
Status:
COMPLETED
Status Verified Date:
2012-05
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
CONVOY
Brief Summary:
The primary objective of this cross-sectional observational real life study is to investigate the patient reported adherence to PPI when prescribed as prevention of NSAID associated GI Ulcers to patients prescribed a NSAID Patients included have Osteoarthritis Rheumatoid Arthritis or Ankylosing Spondylitis Adherence will be assessed by patient questionnaires
Detailed Description:
Cross-sectional observational Real Life study on NSAIDs treated patients with Osteoarthritis Rheumatoid Arthritis and Ankylosing Spondylitis Assessment of patient adherence to PPI treatment
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None